the aid library

LIST OPTIONS

Filter

11153

Compendium of data and evidence-related tools for use in TB planning and programming

World Health Organization WHO (2021) C_WHO

The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)... more

Download (171)

View PDF (211)

Use of COVID-19 evidence in humanitarian settings: the need for dynamic guidance adapted to changing humanitarian crisis contexts

Odlum, A.; R. James; A. Mahieu; et al. Conflict and Health (2021) CC

For humanitarian organisations to respond effectively to complex crises, they require access to up-to-date evidence-based guidance. The COVID-19 crisis has highlighted the importance of updating global guidance to context-specific and evolving needs in humanitarian settings. Our study aimed to under... more

Download (217)

View PDF (241)

Vaccinations to be offered in the absence of documented evidence of prior vaccination

European Centre for Disease Prevention and Control ECDC; WHO Europe (2022) C1

Download (427)

View PDF (633)

IMPROVING HEALTH CARE FINANCING IN ETHIOPIA - An Evidence Brief for Policy

Technology Transfer and Research Translation Directorate of the Ethiopian Public Health Institute (2014) C1

Download (195)

View PDF (240)

Review of Evidence on Antimicrobial Resistance and Animal Agriculture in Developing Countries

Grace, D. International Livestock Research Institute (ILRI) (2015) C2

This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders. The antimicrobial resistant (AMR) infections in anima... more

Download (144)

View PDF (175)

Key Considerations: Emerging evidence on shielding vulnerable groups during COVID-19

Schmidt-Sane M. SSHAP (2020) CC

Shielding is a term used to describe the protection of individuals at high risk of severe COVID-19 illness by separating them from the general population.

External Link

Partnership for Evidence-Based Response for COVID-19 - Profile Dashboard

Partnership for Evidence-Based Response to COVID-19 (PERC) (2021) CC

PERC has developed a dashboard on Tableau to visualize multidisciplinary data and guide decision-makers on their country’s current performance of the COVID-19 response.

External Link

External Link (231)

Reproductive health priorities: evidence from a resource tracking analysis of official development assistance in 2009 and 2010

Hsu J.; Berman P.; Mills A. The Lancet (2013) CC

nformation is scarce about the extent to which official development assistance (ODA) is spent on reproductive health to provide childbirth care; support family planning; address sexual health; and prevent, treat, and care for sexually transmitted infections, including HIV. We analysed flows of ODA t... more

Download (219)

View PDF (236)

Financing the SDGs: Evidence in Four Countries

Jennifer Turner AidData at William & Mary (2019) CC

Achieving the Sustainable Development Goals (SDGs) will require the international community to mobilize significant additional financing over the next decade. Tracking and analyzing this funding is central to measuring progress and making more informed choices to direct financial flows where they wi... more

External Link

Current epidemiological evidence for predisposition to high or low intensity human helminth infection: a systematic review

Wright J.E., Werkman M., Dunn J.C. et al Parasites and Vectors (2018) C2

Background: The human helminth infections include ascariasis, trichuriasis, hookworm infections, schistosomiasis, lymphatic filariasis (LF) and onchocerciasis. It is estimated that almost 2 billion people worldwide are infected with helminths. Whilst the WHO treatment guidelines for helminth infecti...ons are mostly aimed at controlling morbidity, there has been a recent shift with some countries moving towards goals of disease elimination through mass drug administration, especially for LF and onchocerciasis. However, as prevalence is driven lower, treating entire populations may no longer be the most efficient or cost-effective strategy. Instead, it may be beneficial to identify individuals or demographic groups who are persistently infected, often termed as being “predisposed” to infection, and target treatment at them. Methods: The authors searched Embase, MEDLINE, Global Health, and Web of Science for all English language, humanbased papers investigating predisposition to helminth infections published up to October 31st, 2017. The varying definitions used to describe predisposition, and the statistical tests used to determine its presence, are summarised. Evidence for predisposition is presented, stratified by helminth species, and risk factors for predisposition to infection are identified and discussed. Results: In total, 43 papers were identified, summarising results from 34 different studies in 23 countries. Consistent evidence of predisposition to infection with certain species of human helminth was identified. Children were regularly found to experience greater predisposition to Ascaris lumbricoides, Schistosoma mansoni and S. haematobium than adults. Females were found to be more predisposed to A. lumbricoides infection than were males. Household clustering of infection was identified for A. lumbricoides, T. trichiura and S. japonicum. Ascaris lumbricoides and T. trichiura also showed evidence of familial predisposition. Whilst strong evidence for predisposition to hookworm infection was identified, findings with regards to which groups were affected were considerably more varied than for other helminth species. Conclusion: This review has found consistent evidence of predisposition to heavy (and light) infection for certain human helminth species. However, further research is needed to identify reasons for the reported differences between demographic groups. Molecular epidemiological methods associated with whole genome sequencing to determine ‘who infects whom’ may shed more light on the factors generating predisposition. more

Download (195)

View PDF (384)

Building the Evidence Base in Disability Research Summary

International Centre for Evidence in Disability (ICED) London School of Hygiene and Tropical Medicine (LSHTM) (2014) C2

External Link

Oxford COVID-19 Evidence Service

Centre for Evidence-Based Medicine (CEBM); University of Oxford Centre for Evidence-Based Medicine (CEBM); University of Oxford (2020) C2

Accessed: 24.03.2020 The CEBM has committed its skills and expertise in evidence synthesis and dissemination to the effort against the current COVID-19 pandemic. This page will be updated regularly.

Download (128)

View PDF (169)

Guía de práctica clínica: Basada en la evidencia para la atención integral de la sífilis gestacional y congénita (versión corta)

Ministerio de Salud y Protección Social; Fondo de Poblaciones de las Naciones Unidas - UNFPA Asociación Colombiana de Infectiologiá ACIN (2014) C1

Download (247)

View PDF (328)

Directrices de práctica clínica basadas en la evidencia para el seguimiento de recién nacidos en riesgo

Pan American Health Organisation PAHO (2020) C_WHO

Versión abreviada. En esta versión abreviada de las Directrices de práctica clínica basadas en la evidencia para el seguimiento de recién nacidos en riesgo se brindan recomendaciones para la atención de recién nacidos hasta los 2 años y corresponden a la primera fase de su seguimiento. Las r... more

External Link

TUBERCULOSIS INFANTIL Guías basadas en Medicina de la Evidencia 2003

Asociación Colombiana de Neumología Pediátrica (2003) CC

La presente guía tiene además como objetivo, ser un respaldo y no una camisa de fuerza para los médicos, pues pretendemos con ella proveer evidencia sólida respecto a los riesgos, beneficios o consecuencias que puede generar la toma de una decisión en pacientes con tuberculosis. Como lo propone... more

Download (159)

View PDF (154)

Guía de Práctica Clínica: Basada en la evidencia científica para la atención de la infección por VIH en niñas y niños menores de 13 años de edad (versión corta)

Ministerio de Salud y Protección Social, Colombia; Fondo de Poblaciones de las Naciones Unidas - UNFPA Asociación Colombiana de Infectiologiá ACIN (2014) C1

Download (179)

View PDF (158)

Guía de práctica clínica: basada en la evidencia científica para la atención de la infección por VIH/Sida en adolescentes (con 13 años de edad o más) y adultos. (versión larga)

Ministerio de Salud y Protección Social, Colombia; Fondo de Poblaciones de las Naciones Unidas - UNFPA Asociación Colombiana de Infectiologiá ACIN (2014) C1

Download (152)

View PDF (153)

Guía de práctica clínica: Basada en la evidencia para la atención integral de la sífilis gestacional y congénita

Ministerio de Salud y Protección Social; Fondo de Poblaciones de las Naciones Unidas - UNFPA Asociación Colombiana de Infectiologiá ACIN (2014) C1

Download (155)

View PDF (147)

Guía de práctica clínica: basada en la evidencia científica para la atención de la infección por VIH/Sida en adolescentes (con 13 años de edad o más) y adultos. (versión corta)

Ministerio de Salud y Protección Social, Colombia; Fondo de Poblaciones de las Naciones Unidas - UNFPA Asociación Colombiana de Infectiologiá ACIN (2014) C1

Download (235)

View PDF (174)

Guía de práctica clínica: Basada en la evidencia para la atención integral de la sífilis gestacional y congénita (versión larga)

Ministerio de Salud y Protección Social; Fondo de Poblaciones de las Naciones Unidas - UNFPA Asociación Colombiana de Infectiologiá ACIN (2014) C1